|Bid||124.94 x 900|
|Ask||126.14 x 800|
|Day's Range||125.39 - 128.22|
|52 Week Range||86.96 - 131.05|
|Beta (5Y Monthly)||1.31|
|PE Ratio (TTM)||10.78|
|Earnings Date||Nov 01, 2023 - Nov 06, 2023|
|Forward Dividend & Yield||2.80 (2.27%)|
|Ex-Dividend Date||Jul 28, 2023|
|1y Target Est||131.90|
Celanese (CE) monetizes the majority of its Food Ingredients business while maintaining the demand benefits of raw material integration with the Acetyl Chain.
DALLAS, September 27, 2023--Celanese Completes the Formation of Nutrinova, a Food Ingredients Joint Venture with Mitsui
The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.